Precipio Inc. (PRPO)
6.06
0.19 (3.24%)
At close: Jan 14, 2025, 11:35 AM
5.50
-9.24%
Pre-market Jan 15, 2025, 05:55 AM EST
undefined% (undefined)
| Bid | 5 |
| Market Cap | 8.98M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -1.77 |
| PE Ratio (ttm) | -3.42 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 6.49 |
| Volume | 25,617 |
| Avg. Volume (20D) | 6,726 |
| Open | 6.03 |
| Previous Close | 5.87 |
| Day's Range | 6.03 - 6.34 |
| 52-Week Range | 4.31 - 7.30 |
| Beta | undefined |
About PRPO
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; ICE-COLD PCR, a proprietary and patented specimen technology that increases the se...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date Jun 30, 2017
Employees 51
Stock Exchange NASDAQ
Ticker Symbol PRPO
Website https://www.precipiodx.com
6 months ago ·
Source
+23.87%
Precipio shares are trading higher after the compa...
Unlock content with
Pro Subscription
